Inhibition of jun kinase

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/416 (2006.01) A61K 38/45 (2006.01) A61P 3/04 (2006.01) A61P 3/10 (2006.01) A61P 5/50 (2006.01) C12Q 1/48 (2006.01)

Patent

CA 2477842

A method of treating a metabolic disorder associated with insulin resistance by administering to a mammal an inhibitor of a NH2-terminal Jun Kinase (JNK), e.g., a compound or peptide which inhibits JNK1 expression or enzymatic activity.

L'invention concerne un procédé permettant de traiter un trouble métabolique associé à la résistance à l'insuline. Ce procédé consiste à administrer à un mammifère un inhibiteur d'une kinase JNK (NH2-terminal Jun Kinase), par exemple, un composé ou un peptide qui inhibe l'expression de JNK1 ou l'activité enzymatique.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Inhibition of jun kinase does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Inhibition of jun kinase, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibition of jun kinase will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1801515

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.